Upcoming Webinar: The Future Vision for Myelofibrosis and CALR-Driven Disease

This session is designed to provide educational insight into the evolving therapeutic landscape of Myelofibrosis (MF), including emerging strategies for patients with CALR mutations. The presentation will focus on the future vision for MF management, ongoing clinical trials, and the scientific rationale behind new investigational approaches currently under evaluation.

The webinar will explore how advances in molecular understanding are influencing trial design, combination strategies, and potential disease-modifying concepts. It will also review the current stage of clinical development for promising investigational therapies being studied internationally.

Participants can expect a balanced overview of where research stands today, what scientific directions are being explored, and how these developments may shape future conversations between patients and healthcare teams. No claims or guarantees will be made, as all investigational therapies remain subject to ongoing evaluation.

🗓 Date: March 2nd, 2026

🕒 Time: 17:00 CET

💻 Format: Online English webinar with simultaneous interpretation into Spanish

🎙 Speaker: Prof. Haifa Kathrin Al-Ali, MD, Hematologist and International MPN Expert.

The session is open to patients, caregivers, advocates, and healthcare professionals interested in understanding current and future research directions in Myelofibrosis and CALR-mutated disease.

📌 Registration is now open